
Lilach Lerman
Director, Renovascular Disease Research Laboratory · Vanderbilt University Medical Center
Credentials: · · ·
History
- Present
Renovascular Disease Research Laboratory · Vanderbilt University Medical Center
PresentMayo Clinic College of Medicine and Science · Vanderbilt University Medical Center
PresentMayo Clinic College of Medicine and Science · Vanderbilt University Medical Center


- 2026–2027
Internship Rambam Medical Center

- 2022–2026
Israel Institute of Technology
Research
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy · 2016 · 4,439 citations
Endothelial dysfunction: a marker of atherosclerotic risk
Review · Arteriosclerosis · 2003 · 1,772 citations
EBioMedicine · 2019 · 1,102 citations
- AL
471 papers
- XZ
182 papers · 23 as a resident
- ST
112 papers

57 papers · 27 as a fellow

50 papers

48 papers · 19 as a fellow

45 papers · 1 as a fellow

36 papers
Grants
- 2022–2027
Obesity-Induced Dysfunction of Human MSC in Peripheral Microvascular Repair
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.4M · Mayo Clinic Rochester
- 2020–2025
Quantitative Magnetization Transfer MRI for Evaluation of Renal Fibrosis
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.2M · Mayo Clinic Rochester
- 2018–2024
Obesity-Induced Mesenchymal Stem Cell Senescence
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.6M · Mayo Clinic Rochester
- 2020–2024
Noninvasive Evaluation of Renal Allograft Fibrosis by MRI
National Institute on Aging · R21
Contact PI · $413.7K · Mayo Clinic Rochester
Clinical trials
- 2021–2023
Noninvasive Evaluation of Renal Allograft Fibrosis by MRI
Principal investigator · Completed
Mayo Clinic
- 2020–2026
A Study to Evaluate Renal Fibrosis Using MRI Techniques
Principal investigator · Active not recruiting
Mayo Clinic



